DoH accelerates HPV coverage after successful initial drive
This article was originally published in Scrip
Executive Summary
The UK's Department of Healthhas announced a £17 million plan to accelerate a HPV vaccine catch-up scheme in England, following the success of HPV immunisation through primary care trusts across the country. GlaxoSmithKline's Cervarix is used in the UK's vaccination programme.